During glutaminolysis inhibition in colorectal cancer, activating transcription factor 4 (ATF4) is increased to reduce mTOR signaling by transcriptionally activating the mTOR suppressor DNA damage-inducible transcript 4 (DDIT4) [31]. This evidence concerns the gene TCF4 and colorectal cancer.